Literature DB >> 35858329

Quantitative NMR analysis of the kinetics of prenucleation oligomerization and aggregation of pathogenic huntingtin exon-1 protein.

Alberto Ceccon1, Vitali Tugarinov1, Francesco Torricella1, G Marius Clore1.   

Abstract

The N-terminal region of the huntingtin protein, encoded by exon-1 (httex1) and containing an expanded polyglutamine tract, forms fibrils that accumulate in neuronal inclusion bodies, resulting in Huntington's disease. We previously showed that reversible formation of a sparsely populated tetramer of the N-terminal amphiphilic domain, comprising a dimer of dimers in a four-helix bundle configuration, occurs on the microsecond timescale and is an essential prerequisite for subsequent nucleation and fibril formation that takes place orders of magnitude slower on a timescale of hours. For pathogenic httex1, such as httex1Q35 with 35 glutamines, NMR signals decay too rapidly to permit measurement of time-intensive exchange-based experiments. Here, we show that quantitative analysis of both the kinetics and mechanism of prenucleation tetramerization and aggregation can be obtained simultaneously from a series of 1H-15N band-selective optimized flip-angle short-transient heteronuclear multiple quantum coherence (SOFAST-HMQC) correlation spectra. The equilibria and kinetics of tetramerization are derived from the time dependence of the 15N chemical shifts and 1H-15N cross-peak volume/intensity ratios, while the kinetics of irreversible fibril formation are afforded by the decay curves of 1H-15N cross-peak intensities and volumes. Analysis of data on httex1Q35 over a series of concentrations ranging from 200 to 750 μM and containing variable (7 to 20%) amounts of the Met7O sulfoxide species, which does not tetramerize, shows that aggregation of native httex1Q35 proceeds via fourth-order primary nucleation, consistent with the critical role of prenucleation tetramerization, coupled with first-order secondary nucleation. The Met7O sulfoxide species does not nucleate but is still incorporated into fibrils by elongation.

Entities:  

Keywords:  NMR spectroscopy; aggregation kinetics; huntingtin exon-1; nucleation; short-lived excited states

Mesh:

Substances:

Year:  2022        PMID: 35858329      PMCID: PMC9303973          DOI: 10.1073/pnas.2207690119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  48 in total

1.  Solubilization and disaggregation of polyglutamine peptides.

Authors:  S Chen; R Wetzel
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

Review 2.  Secondary nucleation in amyloid formation.

Authors:  Mattias Törnquist; Thomas C T Michaels; Kalyani Sanagavarapu; Xiaoting Yang; Georg Meisl; Samuel I A Cohen; Tuomas P J Knowles; Sara Linse
Journal:  Chem Commun (Camb)       Date:  2018-08-02       Impact factor: 6.222

3.  Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils.

Authors:  J Mario Isas; Ralf Langen; Ansgar B Siemer
Journal:  Biochemistry       Date:  2015-06-16       Impact factor: 3.162

4.  TiO2 Nanoparticles Catalyze Oxidation of Huntingtin Exon 1-Derived Peptides Impeding Aggregation: A Quantitative NMR Study of Binding and Kinetics.

Authors:  Alberto Ceccon; Vitali Tugarinov; G Marius Clore
Journal:  J Am Chem Soc       Date:  2018-12-26       Impact factor: 15.419

Review 5.  Molecular mechanisms and potential therapeutical targets in Huntington's disease.

Authors:  Chiara Zuccato; Marta Valenza; Elena Cattaneo
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

6.  Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent.

Authors:  Karunakar Kar; Murali Jayaraman; Bankanidhi Sahoo; Ravindra Kodali; Ronald Wetzel
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

7.  Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.

Authors:  Ronald Wetzel
Journal:  Acc Chem Res       Date:  2020-09-25       Impact factor: 22.384

8.  Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease.

Authors:  Irina Matlahov; Patrick Ca van der Wel
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-15

9.  Quantitative Exchange NMR-Based Analysis of Huntingtin-SH3 Interactions Suggests an Allosteric Mechanism of Inhibition of Huntingtin Aggregation.

Authors:  Alberto Ceccon; Vitali Tugarinov; G Marius Clore
Journal:  J Am Chem Soc       Date:  2021-06-17       Impact factor: 15.419

10.  Cryo-electron tomography provides topological insights into mutant huntingtin exon 1 and polyQ aggregates.

Authors:  Sarah H Shahmoradian; Koning Shen; Jesús G Galaz-Montoya; Judith Frydman; Wah Chiu
Journal:  Commun Biol       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.